DCC
GILD icon

Dow Chemical Company’s Gilead Sciences GILD Stock Holding History

Dow Chemical Company’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-8,000
Closed -$937K – 104
2015
Q2 		$937K Hold
8,000
– – 0.09% 84
2015
Q1 		$785K Hold
8,000
– – 0.07% 83
2014
Q4 		$754K Hold
8,000
– – 0.07% 75
2014
Q3 		$852K Hold
8,000
– – 0.08% 77
2014
Q2 		$663K Hold
8,000
– – 0.06% 80
2014
Q1 		$567K Sell
8,000
-18,700
-70% -$1.47M 0.05% 80
2013
Q4 		$2.01M Hold
26,700
– – 0.17% 50
2013
Q3 		$1.68M Hold
26,700
– – 0.14% 49
2013
Q2 		$1.37M Buy
+26,700
New +$1.39M 0.12% 47

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dow Chemical Company's GILD Position: Q3 2015 in Review

Dow Chemical Company sold out of Gilead Sciences (GILD) in Q3 2015, closing a stake of 8,000 shares — an estimated $937K sold.

Dow Chemical Company first reported a position in GILD in Q2 2013 and held it in 9 quarters. The position peaked at $2.01M in Q4 2013. 1,572 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Dow Chemical Company reported no remaining Gilead Sciences position as of Q3 2015 after selling out during the quarter.
  • Dow Chemical Company sold 8,000 Gilead Sciences shares in Q3 2015, an estimated $937K.
  • Dow Chemical Company first reported a position in Gilead Sciences in Q2 2013 and held it in 9 quarters.
  • Dow Chemical Company's Gilead Sciences position peaked at $2.01M in Q4 2013.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Dow Chemical Company's 13F filing for Q3 2015, filed 13 Nov 2015.